Sign in or create an account to add this stock to your watchlist.
About WellCare (NYSE:WCG)
WellCare Health Plans, Inc. provides managed care services for government-sponsored health care programs. It operates through three segments: Medicaid Health Plans, Medicare Health Plans, and Medicare PDPs. The Medicaid Health Plans segment offers plans for beneficiaries of temporary assistance for needy families, supplemental security income, and aged blind and disabled residents; and other state-based programs, such as children's health insurance programs and long-term services and supports for qualifying families who are not eligible for Medicaid. The Medicare Health Plans segment provides Medicare, a federal program that provides eligible persons aged 65 and over, as well as some disabled persons with a range of hospital, medical, and prescription drug benefits; Medicare Advantage, a Medicare's managed care alternative to the original Medicare program, which offers individuals standard Medicare benefits directly through Centers for Medicare & Medicaid Services; and coordinated care plans that are administered through health maintenance organizations and require members to seek health care services and select a primary care physician from a network of health care providers. The Medicare PDPs segment provides Medicare part D PDP plans to Medicare-eligible beneficiaries. Its PDP plans offer national in-network prescription drug coverage, including a preferred pharmacy network. As of December 31, 2017, the company served approximately 4.4 million members in 50 states and the District of Columbia. WellCare Health Plans, Inc. was founded in 1985 and is headquartered in Tampa, Florida.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
Trailing P/E Ratio25.53
Forward P/E Ratio21.22
Sales & Book Value
Annual Sales$17.01 billion
Price / Sales0.57
Cash Flow$11.3384 per share
Price / Cash19.18
Book Value$55.91 per share
Price / Book3.89
EPS (Most Recent Fiscal Year)$8.52
Net Income$373.70 million
Return on Equity17.99%
Return on Assets4.74%
WellCare (NYSE:WCG) Frequently Asked Questions
What is WellCare's stock symbol?
WellCare trades on the New York Stock Exchange (NYSE) under the ticker symbol "WCG."
How were WellCare's earnings last quarter?
WellCare (NYSE:WCG) posted its quarterly earnings results on Tuesday, May, 1st. The company reported $2.47 EPS for the quarter, beating the Zacks' consensus estimate of $1.95 by $0.52. The business earned $4.65 billion during the quarter, compared to the consensus estimate of $4.70 billion. WellCare had a return on equity of 17.99% and a net margin of 2.31%. WellCare's revenue for the quarter was up 17.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.61 earnings per share. View WellCare's Earnings History.
When is WellCare's next earnings date?
What guidance has WellCare issued on next quarter's earnings?
WellCare updated its FY18 earnings guidance on Tuesday, May, 1st. The company provided earnings per share guidance of $10.00-10.30 for the period, compared to the Thomson Reuters consensus estimate of $9.82. The company issued revenue guidance of $18.3-18.8 billion, compared to the consensus revenue estimate of $18.78 billion.
What price target have analysts set for WCG?
13 brokers have issued 12 month price targets for WellCare's stock. Their forecasts range from $163.00 to $255.00. On average, they expect WellCare's stock price to reach $222.6154 in the next twelve months. View Analyst Ratings for WellCare.
What are Wall Street analysts saying about WellCare stock?
Here are some recent quotes from research analysts about WellCare stock:
- 1. According to Zacks Investment Research, "WellCare Health’s healthy balance sheet continues to support its operational excellence. The company has also been witnessing revenue growth over the last six years. Following the strong 2017 results, the company raised its guidance for 2018. The company has seen the Zacks Consensus Estimate for 2018 earnings being revised upward in the past 60 days. Although its shares have slightly underperformed the industry in a year’s time, the company’s solid fundamentals are likely to provide further support. However, its rising level of debt hurts the bottom line. Continuous increase in the total expenses also weighs on the margins. The company will release first quarter 2018 results on May 1, 2018." (4/13/2018)
- 2. Cantor Fitzgerald analysts commented, "4Q17 results were solid. Revenue of $4.3 billion was in line with FactSet consensus and our estimate. Favorable prior-year development was $19.6 million. The results included $45.6 million, or $0.64 per share, premium deficiency reserve associated with the company’s new Illinois Medicaid contract. The Illinois PDR was partially offset by continued organic growth and the company’s acquisitions of Universal American, Care 1st Arizona and assets of Phoenix Health Plan. MLR of 88.5% increased 100bps y/y, reflecting the HIF suspension, the effect of Illinois PDR and the acquisition of Universal American. Adjusted EPS of $0.32 were well above consensus of $0.19 and our $0.14 estimate. Due to its focus on profitability, WCG’s net margin improved to 2.25% from 1.9% in 2016. Total membership stood at approximately 4.37 million members. Medicaid membership increased to over 2.7 million people, representing growth of 7% y/y. Medicare organic membership growth was 9% y/y. Management expects mid-single-digit growth in Medicare in 2018." (2/6/2018)
Who are some of WellCare's key competitors?
Who are WellCare's key executives?
WellCare's management team includes the folowing people:
- Mr. Kenneth Alan Burdick, CEO & Director (Age 59)
- Mr. Andrew Lynn Asher, Exec. VP & CFO (Age 49)
- Mr. Michael Robert Polen, Exec. VP of Medicare & Operations (Age 38)
- Ms. Kelly Ann Munson, Exec. VP of Medicaid (Age 46)
- Mr. Michael Paul Radu, Exec. VP of Clinical Operations & Bus. Devel. (Age 50)
Has WellCare been receiving favorable news coverage?
News headlines about WCG stock have been trending somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. WellCare earned a daily sentiment score of 0.12 on Accern's scale. They also assigned media coverage about the company an impact score of 47.83 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.
Who are WellCare's major shareholders?
WellCare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BLACKROCK INC. (10.20%), BlackRock Inc. (10.17%), JPMorgan Chase & Co. (2.46%), American Century Companies Inc. (2.33%), Millennium Management LLC (1.35%) and Russell Investments Group Ltd. (0.92%). Company insiders that own WellCare stock include Andrew Lynn Asher, Carol Burt, Darren Ghanayem, Glenn Md Phd Steele Jr, Kelly A Munson, Kenneth A Burdick, Kevin F Hickey, Michael Robert Polen, Michael Troy Meyer, Paul E Weaver, Roel C Campos and Yount Michael. View Institutional Ownership Trends for WellCare.
Which major investors are selling WellCare stock?
WCG stock was sold by a variety of institutional investors in the last quarter, including Natixis, Prudential Financial Inc., JPMorgan Chase & Co., Wedge Capital Management L L P NC, Fort L.P., Schwab Charles Investment Management Inc., Dimensional Fund Advisors LP and Massachusetts Financial Services Co. MA. Company insiders that have sold WellCare company stock in the last year include Andrew Lynn Asher, Carol Burt, Glenn Md Phd Steele Jr, Kelly A Munson, Kenneth A Burdick, Michael Troy Meyer and Paul E Weaver. View Insider Buying and Selling for WellCare.
Which major investors are buying WellCare stock?
WCG stock was acquired by a variety of institutional investors in the last quarter, including American Century Companies Inc., BlackRock Inc., Millennium Management LLC, Caisse DE Depot ET Placement DU Quebec, Redmile Group LLC, Mackay Shields LLC, OppenheimerFunds Inc. and Point72 Asset Management L.P.. View Insider Buying and Selling for WellCare.
How do I buy shares of WellCare?
Shares of WCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is WellCare's stock price today?
One share of WCG stock can currently be purchased for approximately $217.46.
How big of a company is WellCare?
WellCare has a market capitalization of $9.71 billion and generates $17.01 billion in revenue each year. The company earns $373.70 million in net income (profit) each year or $8.52 on an earnings per share basis. WellCare employs 8,900 workers across the globe.
How can I contact WellCare?
WellCare's mailing address is 8735 HENDERSON ROAD RENAISSANCE ONE, TAMPA FL, 33634. The company can be reached via phone at 813-290-6200 or via email at [email protected]
MarketBeat Community Rating for WellCare (WCG)MarketBeat's community ratings are surveys of what our community members think about WellCare and other stocks. Vote "Outperform" if you believe WCG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WCG will underperform the S&P 500 over the long term. You may vote once every thirty days.
WellCare (NYSE:WCG) Price Target and Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
13 Wall Street analysts have issued ratings and price targets for WellCare in the last 12 months. Their average twelve-month price target is $222.6154, suggesting that the stock has a possible upside of 2.37%. The high price target for WCG is $255.00 and the low price target for WCG is $163.00. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Hold|
|Consensus Rating Score: ||2.77||2.71||2.57||2.41|
|Ratings Breakdown: ||0 Sell Rating(s)|
3 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
10 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$222.6154||$218.00||$218.00||$198.7143|
|Price Target Upside: ||2.37% upside||13.22% upside||11.85% upside||0.36% upside|
WellCare (NYSE:WCG) Consensus Price Target History
WellCare (NYSE:WCG) Analyst Ratings History
(Data available from 5/24/2016 forward)
WellCare (NYSE:WCG) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
WellCare (NYSE WCG) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.59%
Institutional Ownership Percentage: 97.44%
WellCare (NYSE WCG) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|11/7/2017||Carol Burt||Director||Sell||997||$202.20||$201,593.40|| |
|9/14/2017||Kenneth A Burdick||CEO||Sell||8,500||$174.24||$1,481,040.00||23,627|| |
|8/10/2017||Glenn Md Phd Steele Jr||Director||Sell||8,374||$171.97||$1,440,076.78||5,722|| |
|6/15/2017||Kelly A Munson||EVP||Sell||3,000||$173.71||$521,130.00||4,243|| |
|6/14/2017||Andrew Lynn Asher||CFO||Sell||7,314||$175.04||$1,280,242.56||13,244|| |
|6/12/2017||Paul E Weaver||Director||Sell||2,000||$175.44||$350,880.00||15,262|| |
|5/25/2017||Michael Troy Meyer||VP||Sell||600||$171.86||$103,116.00||73|| |
|5/9/2017||Darren Ghanayem||SVP||Sell||800||$170.30||$136,240.00||476|| |
|5/8/2017||Carol Burt||Director||Sell||1,805||$170.09||$307,012.45||8,447|| |
|5/4/2017||Michael Robert Polen||EVP||Sell||6,000||$169.67||$1,018,020.00||12,952|| |
|5/4/2017||Yount Michael||SVP||Sell||2,500||$166.57||$416,425.00||4,804|| |
|3/16/2017||Roel C Campos||Director||Sell||6,000||$143.41||$860,460.00||9,861|| |
|3/15/2017||Kevin F Hickey||Director||Sell||2,707||$142.68||$386,234.76||17,989|| |
|11/18/2016||Paul E Weaver||Director||Sell||3,000||$128.83||$386,490.00||15,892|| |
|8/16/2016||Glenn Md Phd Steele Jr||Director||Sell||10,000||$114.86||$1,148,600.00||10,852|| |
|6/15/2016||Kevin F Hickey||Director||Sell||1,000||$105.56||$105,560.00||14,730|| |
|5/4/2016||Daniel Robert Graham||Director||Sell||2,100||$94.47||$198,387.00||18,713|| |
|3/4/2016||Kevin F Hickey||Director||Sell||4,023||$93.00||$374,139.00||15,300|| |
|3/1/2016||Paul E Weaver||Director||Sell||3,000||$91.65||$274,950.00||14,836|| |
|11/23/2015||Andrew Lynn Asher||CFO||Buy||4,000||$80.71||$322,840.00||3,676|| |
|9/15/2015||Kevin F Hickey||Director||Sell||2,088||$96.43||$201,345.84||17,076|| |
|9/11/2015||Blair Williams Todt||Insider||Sell||1,000||$96.00||$96,000.00||8,548|| |
|6/9/2015||Blair Williams Todt||Insider||Sell||4,000||$81.38||$325,520.00|| |
|3/11/2015||Kevin F Hickey||Director||Sell||3,000||$89.36||$268,080.00|| |
|2/23/2015||Christian P Michalik||Director||Sell||7,544||$89.99||$678,884.56|| |
|12/17/2014||Lawrence Anderson||SVP||Sell||1,536||$75.90||$116,582.40|| |
|12/17/2014||Paul E Weaver||Director||Sell||2,000||$76.52||$153,040.00|| |
|11/6/2014||Blair Williams Todt||SVP||Sell||2,907||$71.95||$209,158.65|| |
|11/6/2014||Thomas L Tran||CFO||Sell||31,667||$70.80||$2,242,023.60|| |
|11/25/2013||Thomas Tran||CFO||Sell||6,898||$73.90||$509,762.20||40,963|| |
|11/13/2013||Alexander Cunningham||Director||Sell||54,305||$67.27||$3,653,097.35|| |
|8/15/2013||Thomas Tran||CFO||Sell||50,000||$65.61||$3,280,500.00||40,963|| |
|8/8/2013||Christian Michalik||Director||Sell||11,657||$65.77||$766,680.89||34,810|| |
|5/14/2013||Charles Berg||Director||Sell||5,000||$57.05||$285,250.00|| |
|5/13/2013||Christian P Michalik||Director||Sell||11,000||$56.80||$624,800.00|| |
|5/10/2013||Alexander R Cunningham||CEO||Sell||5,985||$57.22||$342,461.70|| |
|5/10/2013||Charles Berg||Director||Sell||7,433||$57.26||$425,613.58|| |
|5/8/2013||Charles Berg||Director||Sell||10,000||$56.77||$567,700.00|| |
|11/1/2012||Paul E Weaver||Director||Buy||2,000||$47.95||$95,900.00|| |
WellCare (NYSE WCG) News Headlines
WellCare (NYSE:WCG) SEC Filings
This page is loading this company's SEC Filings. Please wait...
WellCare (NYSE:WCG) Income Statement, Balance Sheet and Cash Flow Statement
WellCare (NYSE WCG) Stock Chart for Thursday, May, 24, 2018